Global Pharmaceuticals / Chemicals Group

Carve Out Planning and Divestment Execution Support Services

Business - Digital - Prof Svcs - MA & D

Client Need

A large chemicals/pharmaceuticals conglomerate wanted to sell one of its chemicals business units in order to fund the purchase of a pharmaceutical business. Due to the integration of the new business, the conglomerate told the target that it must execute the carve out itself with no assistance from the corporate M&A team. The scope of the work was expanded from carve out planning to include the identification and development of business cases for business and IT synergies and to define the new global IT Organisation and Target Operating Model (TOM).

Our Approach

Delivered IT synergies expected as part of Carve Out. Ensured that the banks remained supportive of the deal and the management team. Defined an effective IT organisation for the standalone business. Minimised the costs of Carve Out. Ensured control and effective risk management throughout the engagement.

Outcome delivered

The Aspire team continues to help our client expand and improve the quality of their relationships with their clients providing a 100% return on their investments in our team with a 50% gross margin. With both clients 1 and 2 the relationships developed have also generated other positive spin-off business opportunities by pro-actively providing high quality, collaborative services that add real tangible value recognised by both client examples above.